Christine Blank
Amputation risk possible with diabetes drugs, FDA warns
Based on new data from 2 large clinical trials, FDA is warning that these blockbuster type 2 diabetes medications can cause an increased risk of leg and foot amputations.
FDA expands cystic fibrosis treatment
FDA expanded the use of ivacaftor (Kalydeco, Vertex Pharmaceuticals) to treat cystic fibrosis.
New FDA lead ushers in new era
Scott Gottlieb, MD, was sworn in as the new FDA commissioner and ushers in a new era.
Immuno-oncology bladder drug wins approval
Soon after approving the same drug for metastatic Merkel cell carcinoma, FDA approved immuno-oncology avelumab (Bavencio) for locally advanced or metastatic urothelial carcinoma.
$96.5 Million Generic Payout Latest Trouble for Mylan
A $96.5 million settlement is the latest in a series of pricing and competition issues Mylan has faced in the past year.
How New Biosimilars Will Impact the Market
More biosimilars are coming onto the market , including competitors for Remicade and Neulasta.
How Pharmacists Are Helping Patients with Diabetes in a Rural Area
A study has found that patients with diabetes at a rural clinic have improved health outcomes when they are managed by a pharmacist diabetes clinic.
Three New Digital Tools for People with Diabetes
People with diabetes and health-care professionals have more options for managing their care as more companies create high-tech tools for them. Now, three recently-launched tools and apps will provide more help to pharmacists so that they can help people with diabetes in managing their disease.
Hepatitis C screening recommended by CMS for some beneficiaries
The Centers for Medicare and Medicaid Services (CMS) is accepting public comments until April 3 on its new hepatitis C screening guidelines.